http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103212377-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bff16132c8da634f56320aa3f80c5089
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-28
filingDate 2013-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26f72dc6c626b7e074e018f36c2693c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57da0e6286ccd9bd73a8635c6b48bea5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f1f9ebab61fd073c156d9f232763fd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_072e96a5936b1815d4a30b62d7a0dc29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d96e1842e80e220246a5ef525dc2aa62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74486bb0c92de28087c9607d0180a66d
publicationDate 2014-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103212377-B
titleOfInvention Preparation method of agarose immune magnetic microspheres and applications thereof
abstract The invention discloses a preparation method of agarose immune magnetic microspheres and applications thereof, and relates to a preparation method of microspheres and applications thereof, which solves the technical problems that an existing purified monoclonal antibody is complex in process, is low in yield, and is high in cost, and coupling agents are hypertoxic. The preparation method comprises the following steps of: 1. preparing a ferric oleate precurser; 2. preparing a magnetic fluid; 3. preparing an oil phase and a water phase; 4. preparing agarose magnetic microspheres; 5. preparing activated and crosslinked agarose magnetic microspheres; 6. preparing agarose magnetic microspheres joined with spacer arms; and 7. preparing agarose immune magnetic microspheres. The agarose immune magnetic microspheres provided by the invention are used for purifying genetic engineering recombination trastuzumab monoclonal antibodies. The agarose immune magnetic microspheres prepared by the invention are used for the field of separating and purifying the monoclonal antibodies.
priorityDate 2013-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447791568
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID505709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448419227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454306093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451404211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14923
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449430646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449812109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22959485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68561600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4311764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428054790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415855601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407904790
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID386966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426152218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9920342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3485
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54604155
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6441438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453327643

Total number of triples: 74.